The results demonstrated no difference in the percentage of CD8+ TRM cells in the sham-operation and untreated groups, but increases in the control and knockdown groups, which is consistent with our previous finding of an increased proportion of CD8+ TRM cells in human HCC liver tissues. The gene discussed is CD8A; the disease is hepatocellular carcinoma.